Of four frontrunners in the race for a vaccine for COVID-19 – Moderna, Pfizer and BioNTech, Inovio Pharmaceuticals, and AstraZeneca – is there any indication… Read More »Which Frontrunner’s COVID-19 Vaccine Candidate May Hold The Most Promise – And Why?
Long periods of underperformance by an asset class have historically been followed by extended periods of outperformance, so when it comes to finding the next… Read More »4 Small-Caps Set To Surge
Shares of vaccine specialist Vaxart have exploded an astonishing 4748% so far this year, as investors have piled into the company on the hopes that… Read More »After An Incredible 4748% Surge, Still Plenty Of Room To Run For Vaxart?
Very few investors pay attention to it, but the author of today’s article advises that “this often-overlooked trend can prove useful in finding great stocks.”… Read More »This Often-Overlooked Trend Can Help You Find Great Stocks
While the three biotech penny stocks highlighted in today’s article are risky, each of these under-$5 plays has earned a Moderate or Strong Buy consensus… Read More »3 Biotech Penny Stocks With Substantial COVID-Related Upside Potential
Moderna could strike gold when it comes to its COVID-19 vaccine candidate – or it could flop. Either way, the under-the-radar “picks-and-shovels” stock highlighted in… Read More »Why This “Picks And Shovels” Stock Could Be A Better COVID-19 Play Than Moderna
When it comes to generating explosive returns in the technology sector, the author of today’s article advises that “Narrowing in on relatively small companies within… Read More »“The Shopify Of China” – And Two Other Small Tech Companies That Could Deliver “Market-Crushing” Returns
What makes the clinical-stage biotech highlighted in today’s article, one focused on developing drugs to prevent certain diseases, worth strongly considering? Its most exciting drug… Read More »Its Diabetes-Delaying Drug Could Be A Game-Changer For This Under-The-Radar Biotech
What did the two top-performing biotech stocks last week have in common? As you might expect, and as today’s article notes, “They both delivered positive… Read More »The Top-Performing Biotech Stocks Last Week (Thanks To Their Coronavirus Vaccine Candidates)
When it comes to picking biotech stocks, the author of today’s article declares “I can’t help favoring those with strong, late-stage pipelines and at least… Read More »Why Consider These 3 Biotech Stocks? “Products, Products, And More Products”!